IL33 and skin disorder: Because AD patients exhibit a decreased production of sebum and its microbial metabolite, propionate, a recent study has shown that topical propionate application attenuates skin inflammation in mice with MC903-induced AD-like dermatitis by inhibiting IL-33 production in keratinocytes.